Pediatrix Medical Group (NYSE:MD – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12, Zacks reports. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million.
Pediatrix Medical Group Stock Performance
Shares of NYSE:MD opened at $15.57 on Friday. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $17.67. The firm’s 50 day simple moving average is $13.89 and its two-hundred day simple moving average is $12.96. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.
Analyst Upgrades and Downgrades
MD has been the subject of several recent analyst reports. Jefferies Financial Group lifted their price target on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Macquarie assumed coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday. Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $17.08.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Canadian Penny Stocks: Can They Make You Rich?
- Gilead Sciences: 4 Reasons This Stock Has Much More To Rise
- How to Capture the Benefits of Dividend Increases
- MarketBeat Week in Review – 02/17 – 02/21
- What is the NASDAQ Stock Exchange?
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.